Day: September 13, 2021

NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) — VORNADO REALTY TRUST (NYSE: VNO) today announced the pricing of a public offering of $300 million perpetual 4.45% Series O Cumulative Redeemable Preferred Shares, at a price of $25.00 per share, pursuant to an effective registration statement. The offering is expected to close September 22, 2021, subject to customary closing conditions. The Company may redeem the Series O Preferred Shares at a redemption price of $25.00 per share on and after September 22, 2026. BofA Securities, J.P. Morgan, Morgan Stanley, UBS Investment Bank and Wells Fargo Securities are acting as joint book-running managers. The Company will use the net proceeds for the redemption of its 5.70% Series K Cumulative Redeemable Preferred Shares pursuant to the terms thereof. The offering is being made under the Company’s...

VANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) — Integra Resources Corp. (“Integra” or the “Company”) (TSX-V:ITR; NYSE American:ITRG) is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Raymond James Ltd. (the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 5,900,000 common shares of the Company (the “Common Shares”) at a price of US$2.55 per Common Share (the “Issue Price”), for total gross proceeds of US$15,045,000 (the “Offering”). The Company will also grant to the Underwriters an over-allotment option (the “Over-Allotment Option”) to purchase up to 885,000 additional Common Shares at the Issue Price. The Over-Allotment Option will be exercisable in whole or in part at any time for a period ending 30 days following...

ANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) — Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that Sean Whelan has been appointed to its Board of Directors to fill the vacancy created by the resignation of Christopher Wolfenberg. Robert Cohen, Zomedica’s Chief Executive Officer, commented that: “We all are very pleased to be joined by an executive with Sean’s sterling background. His broad and deep experience and expertise in financial matters, as well as his previous service with publicly listed companies, will be an excellent addition to our Board. I look forward to Sean assuming the Chairmanship of our Audit Committee, and to working with him on a wide variety of issues as Zomedica progresses. I also...

MINNEAPOLIS, Sept. 13, 2021 (GLOBE NEWSWIRE) — Jamf Holding Corp. (“Jamf,” “we,” “us” or “our”) (NASDAQ: JAMF), the standard in Apple Enterprise Management, today announced that it intends to offer, subject to market conditions and other factors, $325.0 million aggregate principal amount of Convertible Senior Notes due 2026 (the “notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Jamf also intends to grant the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the first date on which the notes are issued, up to an additional $48.75 million aggregate principal amount of notes. The notes will be senior unsecured obligations of Jamf and will accrue interest...

PRESS RELEASE Immunocore Announces Upcoming Presentations at the European Society for Medical Oncology (ESMO) Congress 2021 (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US 13 September 2021) Immunocore Holdings Plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, today announces that new data and analysis from the Company’s lead program, tebentafusp, and its proprietary soluble TCR bispecific ImmTAC® platform will be presented at the European Society for Medical Oncology (ESMO) Congress, which will be held virtually from September 16-21, 2021. ORAL PRESENTATIONTitle: Early reduction in ctDNA, regardless of best RECIST...

PRINCETON, N.J., Sept. 13, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it closed its public offering of 23,000,000 shares of common stock at $31.00 per share. The closing includes 3,000,000 shares sold upon full exercise of the underwriters’ option to purchase additional shares of common stock. Certara sold 4,500,000 shares of its common stock, and certain selling stockholders sold 18,500,000 shares of common stock in the offering. The gross proceeds to Certara from the offering were approximately $139.5 million, before deducting the underwriting discount and offering expenses. Certara intends to use the net proceeds from shares it is selling in the offering for general corporate purposes, including acquisitions. Certara did not receive any proceeds from the sale...

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference Mont-Saint-Guibert (Belgium), September 13, 2021, 10:30 pm CET / 4:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Cantor 2021 Global Healthcare Conference on Tuesday, September 28, 2021, with a virtual presentation at 4:00 pm CET/10:00 am ET. A live webcast and replay of this event will be available on the Company’s investors relations website at https://investors.nyxoah.com/ About NyxoahNyxoah is a medical technology company focused on the development and commercialization of innovative solutions...

DENVER, Sept. 13, 2021 (GLOBE NEWSWIRE) — General Cannabis Corp. d/b/a TREES (OTCQB: CANN) (“TREES” or “the Company”), a vertically integrated licensed cannabis operator, is pleased to announce that it has completed the sale of 1,180 Units of Series A Convertible Preferred Equity. Each Unit consists of one share of Series A Convertible Preferred Stock (convertible into 1,000 shares of the Company’s Common Stock) and 300 warrants. The conversion price of the Common Stock at the time of conversion is $1.00 per share, a meaningful premium to the current market price of the Common Stock. The total gross proceeds of the offering was $1,180,000. The Company intends to use the proceeds for additional working capital and general corporate purposes. Furthermore, this infusion of capital strengthens the TREES balance sheet and helps to accelerate...